258 related articles for article (PubMed ID: 19438709)
1. Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation.
Cui W; Ma JW; Lei P; Wu WH; Yu YP; Xiang Y; Tong AJ; Zhao YF; Li YM
FEBS J; 2009 Jun; 276(12):3365-71. PubMed ID: 19438709
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
3. Prevention and promotion effects of apolipoprotein E4 on amylin aggregation.
Lei P; Wu WH; Li RW; Ma JW; Yu YP; Cui W; Zhao YF; Li YM
Biochem Biophys Res Commun; 2008 Apr; 368(2):414-8. PubMed ID: 18243137
[TBL] [Abstract][Full Text] [Related]
4. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
Cho WJ; Jena BP; Jeremic AM
Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
[TBL] [Abstract][Full Text] [Related]
5. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
Nilsson MR; Raleigh DP
J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.
Rijkers DT; Höppener JW; Posthuma G; Lips CJ; Liskamp RM
Chemistry; 2002 Sep; 8(18):4285-91. PubMed ID: 12298020
[TBL] [Abstract][Full Text] [Related]
7. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
[TBL] [Abstract][Full Text] [Related]
8. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
[TBL] [Abstract][Full Text] [Related]
9. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells.
Konarkowska B; Aitken JF; Kistler J; Zhang S; Cooper GJ
FEBS J; 2006 Aug; 273(15):3614-24. PubMed ID: 16884500
[TBL] [Abstract][Full Text] [Related]
10. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
Castillo MJ; Scheen AJ; Lefèbvre PJ
Diabete Metab; 1995 Feb; 21(1):3-25. PubMed ID: 7781840
[TBL] [Abstract][Full Text] [Related]
11. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
[TBL] [Abstract][Full Text] [Related]
12. Backbone-modified amylin derivatives: implications for amyloid inhibitor design and as template for self-assembling bionanomaterials.
Elgersma RC; Posthuma G; Rijkers DT; Liskamp RM
J Pept Sci; 2007 Nov; 13(11):709-16. PubMed ID: 17890652
[TBL] [Abstract][Full Text] [Related]
13. Effects of sequential proline substitutions on amyloid formation by human amylin20-29.
Moriarty DF; Raleigh DP
Biochemistry; 1999 Feb; 38(6):1811-8. PubMed ID: 10026261
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic fibrillar assembly of human amylin.
Goldsbury CS; Cooper GJ; Goldie KN; Müller SA; Saafi EL; Gruijters WT; Misur MP; Engel A; Aebi U; Kistler J
J Struct Biol; 1997 Jun; 119(1):17-27. PubMed ID: 9216085
[TBL] [Abstract][Full Text] [Related]
15. Template-directed self-assembly and growth of insulin amyloid fibrils.
Ha C; Park CB
Biotechnol Bioeng; 2005 Jun; 90(7):848-55. PubMed ID: 15803463
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes.
Cho WJ; Trikha S; Jeremic AM
J Mol Biol; 2009 Oct; 393(3):765-75. PubMed ID: 19720065
[TBL] [Abstract][Full Text] [Related]
17. Amyloid gels: precocious appearance of elastic properties during the formation of an insulin fibrillar network.
Manno M; Giacomazza D; Newman J; Martorana V; San Biagio PL
Langmuir; 2010 Feb; 26(3):1424-6. PubMed ID: 19916492
[TBL] [Abstract][Full Text] [Related]
18. Copper(II) inhibits the formation of amylin amyloid in vitro.
Ward B; Walker K; Exley C
J Inorg Biochem; 2008 Feb; 102(2):371-5. PubMed ID: 18022240
[TBL] [Abstract][Full Text] [Related]
19. Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation.
Nilsson KP; Herland A; Hammarström P; Inganäs O
Biochemistry; 2005 Mar; 44(10):3718-24. PubMed ID: 15751948
[TBL] [Abstract][Full Text] [Related]
20. Osmolyte controlled fibrillation kinetics of insulin: New insight into fibrillation using the preferential exclusion principle.
Nayak A; Lee CC; McRae GJ; Belfort G
Biotechnol Prog; 2009; 25(5):1508-14. PubMed ID: 19653270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
